vida labs tirzepatide Ready to take control of your weight—with medical support? 💊 is now available at Wellness with Master Surgeon in Bariatric & Metabolic Surgery, Dr. Gabriela Rodríguez! This doctor-prescribed treatment helps Tirzepatide Weight Loss Shots in

This nausea usually happens when starting the medication and often gets better over time as the body adjusts

Your provider will consider this when determining the frequency of injections

Here are the average weight loss results based on the dose and timeline: 1 mg: 7.2% in 24 weeks and 8.7% in 48 weeks 4 mg: 12.9% in 24 weeks and 16.3% in 48 weeks 8 mg: 17.3% in 24 weeks and 23.9% in 48 weeks 12 mg: 17.5% in 24 weeks and 24.2% in 48 weeks Placebo: 1.6% in 24 weeks and 2.1% in 48 weeks The retatrutide clinical trials are still ongoing, with a phase IV planned after the current phase III

Product name: Tirzepatide Declared content: 10 mg Receptor profile: GLP-1 and GIP Grade: Research use only Additional notes Important notice: This product is intended strictly for laboratory and scientific research purposes